Wang et al. Supplementary Fig. 2

Aug 15, 2014

10 likes | 96 Vues

mAU. 16.2. BPB. 800. 21.6. BP-3HO. 600. BP-3HHx. 400. 17.4. 200. 0. 16. 18. 20. 22. 24. Time [min]. Wang et al. Supplementary Fig. 2.

Share Presentation

Embed Code

Link

wang et al
supplementary fig
bp-3ho

mostyn

Télécharger la présentation

Wang et al. Supplementary Fig. 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

mAU 16.2 BPB 800 21.6 BP-3HO 600 BP-3HHx 400 17.4 200 0 16 18 20 22 24 Time [min] Wang et al. Supplementary Fig. 2

Supplementary Fig . 1

Supplementary Fig . 1. a DF strain. b DHF strain. c DHF strain. Plasma dengue vRNA copies / ml ( log). Days post inoculation.

79 views • 1 slides

Supplementary Fig. 2

70 views • 1 slides

Shi et al, Supplemental Fig 2

C. B. A. Shi et al, Supplemental Fig 2.

83 views • 1 slides

Lim et al ., Supplemental Fig. 2

A. B. C. D. E. Lim et al ., Supplemental Fig. 2.

65 views • 1 slides

Supplementary Fig 1

Supplementary Fig 1. Supplementary Fig 2. a. b. *p=0.018. p=0.033. p=0.047. *p=0.013. Normal Liver. Control Liver. Normal Liver. Control Liver. Captopril Liver. Captopril Liver. Control Tumor. Control Tumor. Captopril Tumor. Captopril Tumor. Supplementary Fig 3. a. b.

141 views • 4 slides

Supplementary Figure S1 Wang et. al.

Supplementary Figure S1 Wang et. al. Pre-sort. Post-sort. a. 10 5. 4.12. 0.07. 10 4. WT. 10 3. 10 2. 0. 10 5. 5.47. 0.16. 10 4. Bim /. 10 3. 10 2. CD25. 0. 0. 10 2. 10 3. 10 4. 10 5. 0. 10 2. 10 3. 10 4. 10 5. Foxp3. b. Bim /. WT. 10 5. 10 4. 10 3. 10 2.

120 views • 4 slides

Supplementary Fig. 2

a. Stage 1. Stage 2. Stage 3. Stage 4. Stage 5. b. Leaf. Root. Stem. Supplementary Fig. 2

64 views • 1 slides

Wang et al., Supplementary Fig. 1

A. HD-CBsIGF1R. HD-CBGFP. MC-38. KM12SM. hIGF-IR. GAPDH. Wang et al., Supplementary Fig. 1.

105 views • 1 slides

Supplementary Fig. 2.

Supplementary Fig. 2. Blood GSH/ GSSG.

96 views • 1 slides

Supplementary Fig. 2

Supplementary Fig. 2. Mafa-A1*03203. 56. 99. Mafa-A1*03201. Mafa-A1*03204. 94. Mafa-A1*08906. Mafa-A1*08903. 86. 99. Mafa-A1*08907. 89. 58. Mafa-A1*05401. Mafa-A1*06403. 91. 65. Mafa-A1*09701. Mafa-A1*00802. Mafa-A1*05301. 73. Mafa-A1*05202. Mafa-A1*0630302. 96.

89 views • 1 slides

Supplementary Fig. 2:

CD3 positive cell counts. nLBA. nLBA. LBA. LBA. (/mm. (/mm. (/mm. ). ). ). 45. 45. 2. 2. 2. 1400. 1400. 1400. 1400. NS. 40. 40. 35. 35. 1200. 1200. 1200. 1200. *. 30. 30. 1000. 1000. 1000. 1000. 25. 25. 800. 800. 800. 800. 20. 20. 600. 600. 600. 600.

128 views • 1 slides

Biajoux et al. Suppl. Fig 2

Biajoux et al. Suppl. Fig 2. A. B cells. Blood. Ficoll. Cryo. Relative cell number. CXCR4 MFI. B. *. **. % of CXCR4 + CD19 + CD27 - B cells. *. % of CXCR4 + CD19 + total B cells. *. % of CXCR4 + CD19 + CD27 + B cells. % of CXCR4 + CD19 low CD27 high B cells. **.

125 views • 1 slides

Supplementary Fig 2

Supplementary Fig 2.

103 views • 1 slides

Wang B, et al. Sup. Fig 1 (Associated with Fig 3)

Axin2. CD44. Lgr5. **. *. *. *. **. *. Relative mRNA level (normalized by GAPDH ). MKN45. MKN45. MKN45. XN0422. XN0422. XN0422. Wang B, et al. Sup. Fig 1 (Associated with Fig 3).

116 views • 1 slides

Supplementary Fig 2:

Supplementary Fig 2:. MT1. MT2. MT3. MT4.

58 views • 1 slides

Sansone et al, Supplementary Figure 2

HYPO-7. A. 1 MONTH 6 MONTHS 1 YEAR. B. c. 1 MONTH 6 MONTHS 1 YEAR. HYPO-7. MCF-7 + - + - + - HYPO-7 - + - + - +. DFX 600 m M - +. CA-IX.

229 views • 1 slides

Supplementary Fig. 1, Deo et al

Supplementary Fig. 1, Deo et al. VLP-rscFv-SRB homing on cancer cell. Delivery of SRB. Endocytosis. Plasma membrane. VLP-rscFv-SRB. Associated/Packaged SRB. scFv against TAG-72. TAG-72. Cytoplasm.

86 views • 1 slides

Supplementary Fig

Supplementary Fig. RT PCR analysis of luciferase expression in ROSALUC X ROSA26-CreERT 2 and ROSALUC X Alb-CreERT 2 mice RT PCR was performed to analyse luciferase expression in livers of induced or non-induced ROSALUC X Alb-CreERT 2 and ROSALUC X ROSA26-CreERT 2 .

113 views • 1 slides

Supplementary Figure 2. Kunogi M et al.

1000. 503. 500. 400. 281. 300. 200. NC. PC. PT. t. g. t. c. c. c. t. c. c. a. g. G. T. C. T. G. C. C. C. Supplementary Figure 2. Kunogi M et al. control. A. intron 5. exon 6. bp. 1000. deletion. reverse. reverse. t. g. t. c. T. G. C. C. C. T. G. G.

73 views • 1 slides

Supplementary Figure 2 Hori et al.

ProteoExtract Protein Precipitation Kit Protocol (Illustrated). Supplementary Figure 2 Hori et al.

106 views • 1 slides

Vickerman et al., Supplementary Fig. 1

A. B. Control. Shox2 c/-. FL. FL. E10.5 Igf1. C. D. FL. E10.5 Tiparp. FL. E. F. E11.5 Lmo1. G. H. E11.5 Mlf1. I. J. E11.5 Prrx1. Vickerman et al., Supplementary Fig. 1.

118 views • 1 slides

Supplementary data Fig 2

Supplementary data Fig 1: Comparison of differential mRNA expression data obtained by qRT-PCR and microarray (relative expression in tumors compared to normal tissues) .

114 views • 10 slides

More Related